Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.
- Antibiotic resistance
- Opportunistic infection
- Septic shock
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology